The impact of therapeutic drug monitoring in neonatal clinical pharmacology

Clin Biochem. 2014 Jun;47(9):704-5. doi: 10.1016/j.clinbiochem.2014.05.018. Epub 2014 May 19.

Author

Johannes N van den Anker¹

Affiliation

¹ Division of Pediatric Clinical Pharmacology, Children's National Health System, Washington, DC, USA; Intensive Care, Erasmus MC-Sophia Children's Hospital, Rotterdam, The Netherlands; Department of Paediatric Pharmacology, University Children's Hospital Basel, Switzerland. Electronic address: jvandena@childrensnational.org.

PMID: 24854683
DOI: 10.1016/j.clinbiochem.2014.05.018

No abstract available

MeSH terms

Anti-Bacterial Agents / pharmacology*
Anti-Bacterial Agents / therapeutic use
Bacterial Infections / drug therapy
Drug Monitoring*
Humans
Infant, Newborn
Infant, Newborn, Diseases / drug therapy
Intensive Care Units, Neonatal
Microbial Sensitivity Tests
Quality Improvement
Treatment Outcome

Substances

Anti-Bacterial Agents